Competition Agency Warns India Pharma Against Industry Practices
This article was originally published in PharmAsia News
Executive Summary
The Competition Commission of India is looking into anticompetitive behavior in the nation's pharmaceutical industry. The CCI has asked industry representatives to discuss the way they set prices and market and sell their goods at the retail level. Current practices do not reflect the competitive spirit, the CCI says. Discussions are considered a prelude to official action against anticompetitive practices. (Click here for more